Dai-ichi Life Insurance Company’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,430
| Closed | -$449K | – | 487 |
|
|
2024
Q4 | $449K | Hold |
2,430
| – | – | 0.01% | 458 |
|
|
2024
Q3 | $479K | Sell |
2,430
-1,000
| -29% | -$197K | 0.01% | 460 |
|
|
2024
Q2 | $709K | Sell |
3,430
-6,000
| -64% | -$1.24M | 0.02% | 401 |
|
|
2024
Q1 | $2.56M | Hold |
9,430
| – | – | 0.06% | 270 |
|
|
2023
Q4 | $2.23M | Sell |
9,430
-17,850
| -65% | -$4.22M | 0.05% | 288 |
|
|
2023
Q3 | $5.35M | Sell |
27,280
-1,764
| -6% | -$346K | 0.12% | 159 |
|
|
2023
Q2 | $6.11M | Buy |
29,044
+3,350
| +13% | +$704K | 0.13% | 146 |
|
|
2023
Q1 | $5.19M | Sell |
25,694
-14,000
| -35% | -$2.83M | 0.11% | 170 |
|
|
2022
Q4 | $8.65M | Hold |
39,694
| – | – | 0.2% | 102 |
|
|
2022
Q3 | $7.81M | Hold |
39,694
| – | – | 0.19% | 106 |
|
|
2022
Q2 | $8.49M | Buy |
39,694
+194
| +0.5% | +$41.5K | 0.19% | 105 |
|
|
2022
Q1 | $11.2M | Buy |
39,500
+2,000
| +5% | +$568K | 0.18% | 117 |
|
|
2021
Q4 | $14.1M | Buy |
37,500
+9,500
| +34% | +$3.58M | 0.18% | 108 |
|
|
2021
Q3 | $11.6M | Hold |
28,000
| – | – | 0.15% | 124 |
|
|
2021
Q2 | $10.4M | Buy |
28,000
+8,000
| +40% | +$2.96M | 0.13% | 141 |
|
|
2021
Q1 | $5.8M | Buy |
+20,000
| New | +$5.8M | 0.08% | 190 |
|